Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

BACKGROUND: As the use of Integrase inhibitor (INSTI)-class antiretroviral medications becomes more common to maintain long-term viral suppression, early reports suggest the potential for CNS side-effects when starting or switching to an INSTI-based regimen. In a population already at higher risk fo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:AIDS Behav
Glavni autori: Kamkwalala, Asante R., Wang, Kunbo, O’Halloran, Jane, Williams, Dionna W., Dastgheyb, Raha, Fitzgerald, Kathryn C., Spence, Amanda B., Maki, Pauline M., Gustafson, Deborah R., Milam, Joel, Sharma, Anjali, Weber, Kathleen M., Adimora, Adaora A., Ofotokun, Igho, Sheth, Anandi N., Lahiri, Cecile D., Fischl, Margaret A., Konkle-Parker, Deborah, Xu, Yanxun, Rubin, Leah H.
Format: Artigo
Jezik:Inglês
Izdano: 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948485/
https://ncbi.nlm.nih.gov/pubmed/32638219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02967-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items